Third Harmonic Bio Announces Pricing of Upsized Initial
CAMBRIDGE, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a...
Source: globenewswire.com
Page 3 - Third Harmonic News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Third Harmonic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Third Harmonic Today - Breaking & Trending Today
Third Harmonic pushes IPO window open with inflammation drug from Novartis
Third Harmonic Bio, which emerged from stealth early this year with a lead drug from Novartis and a $105 million round of funding, has not yet set any financial terms for its planned IPO. But the biotech plans to use the IPO cash for clinical early and mid-stage clinical tests of its small molecule in multiple inflammatory indications.
Source: medcitynews.com